Girard Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,909
| Closed | -$224K | – | 249 |
|
|
2023
Q2 | $224K | Sell |
2,909
-72
| -2% | -$5.74K | 0.02% | 239 |
|
|
2023
Q1 | $247K | Buy |
2,981
+73
| +3% | +$6.05K | 0.03% | 227 |
|
|
2022
Q4 | $250K | Buy |
+2,908
| New | +$230K | 0.03% | 235 |
|
|
2021
Q4 | – | Sell |
-4,251
| Closed | -$296K | – | 260 |
|
|
2021
Q3 | $296K | Sell |
4,251
-2,221
| -34% | -$156K | 0.04% | 195 |
|
|
2021
Q2 | $445K | Sell |
6,472
-1,254
| -16% | -$83.7K | 0.06% | 169 |
|
|
2021
Q1 | $499K | Buy |
7,726
+6
| +0.1% | +$387 | 0.07% | 148 |
|
|
2020
Q4 | $449K | Buy |
+7,720
| New | +$466K | 0.07% | 153 |
|
|
2020
Q3 | – | Sell |
-4,092
| Closed | -$314K | – | 213 |
|
|
2020
Q2 | $314K | Sell |
4,092
-565
| -12% | -$43.3K | 0.06% | 173 |
|
|
2020
Q1 | $348K | Buy |
4,657
+281
| +6% | +$19.4K | 0.07% | 165 |
|
|
2019
Q4 | $284K | Sell |
4,376
-190
| -4% | -$12.4K | 0.05% | 197 |
|
|
2019
Q3 | $289K | Sell |
4,566
-5,194
| -53% | -$340K | 0.05% | 185 |
|
|
2019
Q2 | $659K | Buy |
9,760
+331
| +4% | +$21.8K | 0.12% | 137 |
|
|
2019
Q1 | $613K | Buy |
9,429
+274
| +3% | +$18.2K | 0.11% | 141 |
|
|
2018
Q4 | $572K | Sell |
9,155
-5,004
| -35% | -$350K | 0.12% | 143 |
|
|
2018
Q3 | $1.09M | Sell |
14,159
-810
| -5% | -$61.2K | 0.19% | 113 |
|
|
2018
Q2 | $1.06M | Sell |
14,969
-2,261
| -13% | -$160K | 0.2% | 117 |
|
|
2018
Q1 | $1.3M | Sell |
17,230
-4,274
| -20% | -$340K | 0.3% | 84 |
|
|
2017
Q4 | $1.54M | Sell |
21,504
-5,495
| -20% | -$417K | 0.3% | 91 |
|
|
2017
Q3 | $2.19M | Sell |
26,999
-964
| -3% | -$73.7K | 0.45% | 67 |
|
|
2017
Q2 | $1.98M | Sell |
27,963
-3,875
| -12% | -$258K | 0.43% | 70 |
|
|
2017
Q1 | $2.16M | Buy |
31,838
+1,116
| +4% | +$78.5K | 0.52% | 63 |
|
|
2016
Q4 | $2.2M | Sell |
30,722
-1,824
| -6% | -$136K | 0.64% | 55 |
|
|
2016
Q3 | $2.58M | Buy |
32,546
+4,492
| +16% | +$365K | 0.86% | 41 |
|
|
2016
Q2 | $2.34M | Buy |
28,054
+1,873
| +7% | +$166K | 0.89% | 41 |
|
|
2016
Q1 | $2.4M | Buy |
26,181
+3,335
| +15% | +$301K | 1.05% | 30 |
|
|
2015
Q4 | $2.31M | Buy |
22,846
+2,739
| +14% | +$285K | 1.12% | 27 |
|
|
2015
Q3 | $1.97M | Buy |
20,107
+2,042
| +11% | +$227K | 1.12% | 31 |
|
|
2015
Q2 | $2.12M | Buy |
18,065
+117
| +0.7% | +$12.8K | 1.18% | 28 |
|
|
2015
Q1 | $1.76M | Buy |
17,948
+1,585
| +10% | +$161K | 1.04% | 37 |
|
|
2014
Q4 | $1.54M | Sell |
16,363
-1,908
| -10% | -$197K | 0.96% | 39 |
|
|
2014
Q3 | $1.95M | Sell |
18,271
-565
| -3% | -$55.3K | 1.3% | 29 |
|
|
2014
Q2 | $1.56M | Buy |
18,836
+2,711
| +17% | +$211K | 1.08% | 34 |
|
|
2014
Q1 | $1.14M | Buy |
16,125
+9,311
| +137% | +$730K | 0.81% | 44 |
|
|
2013
Q4 | $512K | Buy |
+6,814
| New | +$474K | 0.41% | 67 |
|
Other funds holding GILD
Girard Partners's GILD Position: Q3 2023 in Review
Girard Partners sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 2,909 shares — an estimated $224K sold.
Girard Partners first reported a position in GILD in Q4 2013 and held it in 34 quarters. The position peaked at $2.58M in Q3 2016. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.
- Girard Partners reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
- Girard Partners sold 2,909 Gilead Sciences shares in Q3 2023, an estimated $224K.
- Girard Partners first reported a position in Gilead Sciences in Q4 2013 and held it in 34 quarters.
- Girard Partners's Gilead Sciences position peaked at $2.58M in Q3 2016.
- 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.
Based on Girard Partners's 13F filing for Q3 2023, filed 2 Nov 2023.